Aortic valve stents to prevent paravalvular leaks
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NINGBO JENSCARE BIOTECHNOLOGY CO LTD
- Publication Date
- 2015-10-21
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The invention belongs to the field of medical devices, and in particular relates to an aortic valve stent for preventing paravalvular leakage. Background technique:
[0002] Aortic valve stenosis is a common heart valve disease in the elderly. The incidence rate is about 4% in patients aged 75-85, and increases to about 7% in patients over 85 years old. Among them, the incidence of aortic valve stenosis due to aortic valve calcification reaches 2%-7%, and with the increase of age, its proportion increases, and it has become an important cause of heart failure, arrhythmia, syncope and sudden death in the elderly one. Surgical valve replacement is the first traditional treatment method, but the mortality rate is very high for patients with advanced age, low heart function or multiple complications. Symptoms and recurrence rates are high.
[0003] Since 2002, Cribier et al took the lead in reporting the first case of human percutaneous aortic valve re...